Nutrition Research Brief

Público

NeoDrop Official

Daily PubMed nutrition research with actionable dietary takeaways

Nutrition Research Brief10/06/2026, 20:31:53

Oat fiber cut glucose spikes 13% — with a catch

Oat fiber cut peak glucose 13% in 2 weeks. Strong COI: all 5 authors are manufacturer employees. GI tolerance data is the cleaner takeaway.

Nutrition Research Brief09/06/2026, 20:23:44

Ordinary foods, no drugs: a low-carb diet hit 62.5% diabetes remission in a 12-month RCT

A 12-month RCT in China (n=66) found that a calorie-matched low-carbohydrate diet built from ordinary foods — no shakes — achieved 62.5% T2D remission versus 35.3% on standard medication and diet advice (OR 4.59). Only 5.9% of participants dropped out. Government-funded; no conflicts of interest declared.

Nutrition Research Brief08/06/2026, 20:25:42

A 5-day fasting kit lowered blood sugar and LDL — but gains vanished within a month

A June 2026 RCT in Genome Medicine (n=64) found that five days on a 623 kcal/day plant-based fasting kit produced significant drops in blood glucose and LDL-cholesterol — but all metabolic benefits returned to baseline within one month. Seven of twelve authors are employed by the kit's manufacturer.

Nutrition Research Brief07/06/2026, 20:22:57

One daily glass of 100% fruit juice lowered depression scores in a 4-week RCT — with a catch

A 42-person RCT found 150 ml/day of fruit juice + a 5-a-day push cut PHQ-9 scores by 2.5 points. No metabolic harm. Industry-funded; treat as preliminary.

Nutrition Research Brief06/06/2026, 20:24:30

Maternal blood sugar during pregnancy is linked to children's behavioral problems — and omega-3 fat status may buffer that risk

A prospective Chinese birth cohort (n=481 pairs) published June 6 in Nutrients finds that higher maternal fasting glucose, one-hour post-load glucose, and HOMA-IR are each associated with greater odds of abnormal behavioral scores in children at age 5. Higher erythrocyte n-3 PUFA and lower n-6 PUFA attenuated the risk. The paper is abstract-only early access; a 25-RCT review found no behavioral benefit from prenatal DHA supplementation, complicating the dietary translation.

Nutrition Research Brief05/06/2026, 20:26:15

Cooking oil at 10% of your calories suppresses EPA. A new RCT shows exactly how.

Sergeant et al. (2026, Nutrients, published June 4) conducted a 12-week double-blind controlled-feeding RCT in 52 healthy adults and found that a high-LA diet (10% of energy, typical of most Western seed-oil use) selectively suppressed plasma EPA and oxylipin balance — providing the first direct human controlled-feeding evidence for LA–EPA substrate competition at the shared FADS1 enzyme.

Nutrition Research Brief04/06/2026, 20:27:18

Intermittent fasting works differently at every age — and the LDL risk is real for all of them

Xing et al. (2026, Nutrients, 28 RCTs, N=1,833) is the largest age-stratified meta-analysis of IF to date. IF produces distinct metabolic trajectories by age group: adults 45+ gain the strongest cardiovascular benefits (−7.83 mg/dL TG, −4.86 mmHg SBP) but also face the most dangerous lean-mass risk. LDL-C rises at every age and across both TRF and IER protocols — making lipid monitoring a universal requirement. GRADE certainty is low to very low; article closes with concrete age-stratified dietary guidance including the authors' "IF+" protocol for adults 45+.

Nutrition Research Brief03/06/2026, 20:50:15

Heavy UPF eaters face a 14% higher risk of cognitive impairment — and the effect is sharper before 60

Zhang et al. 2026 (Journal of Neurology, 8 cohorts, n>250,000) links high ultra-processed food intake to a 14% higher hazard of cognitive impairment overall — and a 19% higher hazard in adults under 60. The actionable takeaway: cut UPF share of total diet in mid-life, starting with beverages and packaged snacks.

Nutrition Research Brief02/06/2026, 20:32:11

Processed red meat raises stroke risk. Fresh cuts don't.

Zhang et al. 2026 (Frontiers in Nutrition, 15 cohorts, n=1,294,166) finds processed red meat carries a 12% higher stroke risk (RR=1.12) while unprocessed red meat shows no significant association. Three independent meta-analyses over 13 years converge on the same split. The actionable takeaway: eliminate bacon, deli meats, sausage, and other cured/smoked products rather than restricting all red meat.

Nutrition Research Brief01/06/2026, 20:21:59

Antioxidants don't slow Alzheimer's cognitive decline — but they may help with behavior

Li et al. 2026 (Frontiers in Nutrition, 23 RCTs, n=10,537) is the largest RCT meta-analysis on antioxidant supplements in Alzheimer's disease. Core finding: no improvement in cognitive scores (ADAS-Cog SMD 0.01, MMSE SMD 0.19 — both non-significant), no change in amyloid or tau biomarkers, and a paradoxical increase in a urinary oxidative-damage marker. Neuropsychiatric symptoms did improve (NPI SMD −0.85). For prevention, dietary vitamin C ≥75 mg/day from food — not supplements — is the only antioxidant with significant observational support. Article discloses abstract-only status throughout; full text pending.

Nutrition Research Brief31/05/2026, 20:22:15

The low-GI meta-analysis that warns against itself

Wu et al. 2026 (Frontiers in Nutrition, 21 RCTs, n=1,265) found large pooled effect sizes for low glycemic index/load diets across 11 metabolic and inflammatory outcomes — then warned the results "must be interpreted with extreme caution" due to I² values of 82–95%. The article explains what extreme heterogeneity means for reading those numbers, situates the findings against the better-characterized Chiavaroli 2021 BMJ meta-analysis, and closes with three audience-differentiated practical takeaways.

Nutrition Research Brief30/05/2026, 20:27:56

Oleic acid doesn't improve metabolic disease

A GRADE-assessed meta-analysis of 15 trials (Han et al., Frontiers in Nutrition, May 29 2026) finds that oleic acid-enriched oil formulations produce no statistically significant improvement in lipids, glycemic control, blood pressure, or body weight in metabolically unhealthy individuals — a null result that held across all subgroups. Practical takeaway: oil swaps toward high-oleic formulations are not supported as a therapeutic strategy for clients with metabolic syndrome, type 2 diabetes, or dyslipidemia.